Feasibility Study of Simvastatin in Hodgkin's Lymphoma Survivors

NCT00746603 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped Poor enrollment

Conditions

Carotid Artery Disease

Interventions

DRUG: Simvastatin

Sponsor

Columbia University

Collaborators

[object Object]